NEW YORK, April 18, 2023 /PRNewswire/ — The pulmonary arterial hypertension (PAH) drugs market size is forecasted to increase by USD 2,080.07 million from 2022 to 2027, at a CAGR of 6.62%, according to the recent market study by Technavio. The growth of the market will be driven by the…